VITROS(R) 3600 Immunodiagnostic System Receives 510(k) Clearance From The FDA
Ortho Clinical Diagnostics announced 510(k) clearance from the United States Food and Drug Administration (U.S. FDA) for its VITROS(R) 3600 Immunodiagnostic System. This new high-capacity immunoassay system provides laboratories with a truly innovative solution to address their quality, labor and cost challenges. The VITROS(R) 3600 delivers high-quality and dependable results by offering a broad and comprehensive immunoassay menu based on world-class VITROS(R) technologies. This is the second clearance for Ortho Clinical Diagnostics this quarter, following 510(k) clearance of the VITROS(R) 5600 Integrated System in October.
- First HIV diagnostic assay approved
- Thermo Fisher receives US market clearance for MRSA test
- FDA clearance to MiCardia for marketing Dynaplasty™ Annuloplasty devices
- Clear Catheter Systems Receives Major International Innovation Award
